Randomized phase III trial investigating the survival benefit of adding thoracic radiotherapy to durvalumab (MEDI4736) immunotherapy plus chemotherapy in extensive stage small-cell lung cancer
Latest Information Update: 12 Apr 2024
At a glance
- Drugs Durvalumab (Primary) ; Antineoplastics
- Indications Brain metastases; Small cell lung cancer
- Focus Therapeutic Use
- Acronyms TRIPLEX
Most Recent Events
- 15 Sep 2022 New trial record